U.S. Markets open in 43 mins
  • S&P Futures

    4,190.75
    +66.25 (+1.61%)
     
  • Dow Futures

    33,139.00
    +402.00 (+1.23%)
     
  • Nasdaq Futures

    13,316.75
    +285.25 (+2.19%)
     
  • Russell 2000 Futures

    1,947.60
    +33.00 (+1.72%)
     
  • Crude Oil

    90.00
    -0.50 (-0.55%)
     
  • Gold

    1,822.30
    +10.00 (+0.55%)
     
  • Silver

    20.69
    +0.21 (+1.02%)
     
  • EUR/USD

    1.0340
    +0.0123 (+1.1995%)
     
  • 10-Yr Bond

    2.6840
    -0.1130 (-4.04%)
     
  • Vix

    22.14
    +0.85 (+3.99%)
     
  • GBP/USD

    1.2242
    +0.0166 (+1.3761%)
     
  • USD/JPY

    132.8610
    -2.2550 (-1.6689%)
     
  • BTC-USD

    23,699.77
    +391.35 (+1.68%)
     
  • CMC Crypto 200

    554.11
    -3.24 (-0.58%)
     
  • FTSE 100

    7,515.09
    +26.94 (+0.36%)
     
  • Nikkei 225

    27,819.33
    -180.67 (-0.65%)
     

Applied UV Receives MedLine Follow-On Order For Air Purification System

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Applied UV Inc (NASDAQ: AUVI) said its exclusive North American Scientific Air Management healthcare distribution partner MedLine had placed a follow-on order for its patented S200 mobile air purification system.

  • The order is in support of the company’s Centers for Medicare and Medicaid Services (CMS) Policy.

  • The CMS policy provides funding available for long-term care providers looking to make air quality upgrades to their facilities to reduce the spread of COVID-19.

  • “Our Scientific Air Management S-200 is a mobile, easy-to-use solution to mitigate against the spread of respiratory infections in long-term care facilities creating a cleaner and safer environment for visitation,” said CEO John F. Andrews.

  • Price Action: AUVI shares are trading lower by 5.02% at $2.08 on the last check Tuesday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.